Live Breaking News & Updates on Pacific biosciences

Stay informed with the latest breaking news from Pacific biosciences on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Pacific biosciences and stay connected to the pulse of your community

Skechers Reports Upbeat Earnings, Joins Tutor Perini, AppFolio, Newell Brands And Other Big Stocks Moving Higher On Friday - Skechers USA (NYSE:SKX), Newell Brands (NASDAQ:NWL), Tutor Perini (NYSE:TPC), AppFolio (NASDAQ:APPF)

California , United-states , Rogers-corporation , Geron-corporation , Pacific-biosciences , Perini-corporation , Raymond-james , John-murphy , Xpeng-inc , Kb-financial-group-inc , Services-ltd , Cullinan-therapeutics-inc

Genomics Market size in US to record USD 5.28 billion growth from 2023-2027, Growing adoption of single cell-based genomics analysis is one of the key market trends, Technavio

/PRNewswire/ -- The genomics market size in US is estimated to grow by USD 5.28 billion from 2023 to 2027, according to Technavio. The market is estimated to...

United-kingdom , United-states , America , Jesse-maida , Pacific-biosciences , National-human-genome-research-institute , Academic-and-research-institutes , Biotechnology-companies , Technavio-research , Trends-fueling-growth , Genomics-market , Next-generation-sequencing

Sanford C. Bernstein Lowers Pacific Biosciences of California (NASDAQ:PACB) Price Target to $2.50

Pacific Biosciences of California (NASDAQ:PACB – Free Report) had its target price reduced by Sanford C. Bernstein from $9.00 to $2.50 in a report released on Thursday morning, Benzinga reports. They currently have an outperform rating on the biotechnology company’s stock. A number of other research firms have also weighed in on PACB. Scotiabank cut […]

California , United-states , Sanfordc-bernstein , Oene-mark-van , Davidw-meline , Pacific-biosciences , California-company-profile , Comerica-bank , Securities-exchange-commission , California-inc , Kayne-anderson-rudnick-investment-management , Goldman-sachs-group

Equities Research Analysts' Updated EPS Estimates for April 22nd (ARCH, ASND, BATS, BBSI, BHB, BME, BMTX, BP, CALX, CCL)

Equities Research Analysts’ updated eps estimates for Monday, April 22nd: Arch Resources (NYSE:ARCH) had its buy rating reiterated by analysts at Benchmark Co.. They currently have a $180.00 price target on the stock. Ascendis Pharma A/S (NASDAQ:ASND) had its equal weight rating reaffirmed by analysts at Morgan Stanley. They currently have a $116.00 price target […]

United-states , California , America , American , Roth-mkm , William-blair , Piper-sandler , Raymond-james , Ascendis-pharma , Pacific-biosciences , Barrington-research , Equities-research-analyst

Pacific Biosciences of California (NASDAQ:PACB) PT Lowered to $8.00 at Scotiabank

Pacific Biosciences of California (NASDAQ:PACB – Free Report) had its price objective reduced by Scotiabank from $15.00 to $8.00 in a report published on Thursday, Benzinga reports. They currently have a sector outperform rating on the biotechnology company’s stock. Several other equities research analysts have also weighed in on PACB. Barclays reduced their target price […]

California , United-states , Pacific-biosciences , Davidw-meline , Oene-mark-van , Barclays , Envestnet-asset-management-inc , Scotiabank , Goldman-sachs-group , Group-plc , Ambassador-advisors , Prudential-financial-inc

Scotiabank Lowers Pacific Biosciences of California (NASDAQ:PACB) Price Target to $8.00

Pacific Biosciences of California (NASDAQ:PACB – Free Report) had its price objective cut by Scotiabank from $15.00 to $8.00 in a report published on Thursday, Benzinga reports. They currently have a sector outperform rating on the biotechnology company’s stock. A number of other research firms also recently weighed in on PACB. The Goldman Sachs Group […]

California , United-states , Oene-mark-van , Davidw-meline , Pacific-biosciences , Prudential-financial-inc , Group-plc , Envestnet-asset-management-inc , Scotiabank , California-inc , Goldman-sachs-group , Ambassador-advisors

Pacific Biosciences of California (NASDAQ:PACB) Upgraded by StockNews.com to "Sell"

Pacific Biosciences of California (NASDAQ:PACB) Upgraded by StockNews.com to "Sell"
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

California , United-states , Oene-mark-van , Pacific-biosciences , Davidw-meline , Investment-management , Barclays , Qube-research-technologies-ltd , Goldman-sachs-group , Moody-aldrich-partners , Securities-exchange-commission , California-inc

StockWatch: PacBio Faces Uphill Climb as Q1 Revenue Falls Short

StockWatch: PacBio Faces Uphill Climb as Q1 Revenue Falls Short
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

China , Germany , United-states , Philadelphia , Pennsylvania , Chinese , Alex-dickinson , Ubrigene-jiangsu-biosciences , Dan-brennan , Susan-kim , Andrewj-teno , Canaccord-genuity

TD Cowen Lowers Pacific Biosciences of California (NASDAQ:PACB) Price Target to $2.50

TD Cowen Lowers Pacific Biosciences of California (NASDAQ:PACB) Price Target to $2.50
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Blackrock , California , United-states , Pacific-biosciences , Oene-mark-van , Davidw-meline , Securities-exchange-commission , Barclays , Vanguard-group-inc , California-inc , Pricet-rowe-associates-inc , Capital-international-investors

Pacific Biosciences of California (NASDAQ:PACB) Given New $2.50 Price Target at Sanford C. Bernstein

Pacific Biosciences of California (NASDAQ:PACB – Free Report) had its target price trimmed by Sanford C. Bernstein from $9.00 to $2.50 in a research note released on Thursday morning, Benzinga reports. The firm currently has an outperform rating on the biotechnology company’s stock. A number of other equities research analysts have also recently commented on […]

California , United-states , Sanfordc-bernstein , Davidw-meline , Oene-mark-van , Pacific-biosciences , Goldman-sachs-group , Barclays , Nasdaq , Qube-research-technologies-ltd , California-inc , Securities-exchange-commission